Pharmaceuticals

Global Neuroprotective Products Market (Class of Drugs, Treatment of Medical Conditions and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

  • ALL22806
  • 0 Pages
  • November 1999
  • Pharmaceuticals

Neuroprotective products are medications that protect the brain neurons from degeneration and injury. These products are used in the treatment of several central nervous system complications such as Parkinson's disease, Alzheimer's disease, and traumatic brain injuries among others. Neurodegenerative diseases and their prevalence increases significantly with age. Hence, the demand for neuroprotectives would increase in the future, as average life spans are increasing, which opens up a huge market for novel drugs for the treatment of these diseases. The drivers for this market are the increasing incidence and prevalence of neurodegenerative diseases, especially in aging populations and a need for the treatment of brain injuries caused chiefly by road accidents. However, high costs involved in research and development, strict regulatory approvals and the high failure rate of majority of the prospective drugs in clinical trials would restrict growth in this market. With the high prevalence rates of neurogenerative disease and the lack of specific treatment options, the opportunities are tremendous for the entry of novel drugs.

Neuroprotective Products Market by Class of Drugs
The neuroprotective drugs are Cholinesterase inhibitors, NMDA receptor antagonists, Ion channel modulators, Anti-inflammatory and anti-apoptotic agents, Mitochondrial dysfunction regulators Neurotropic factors, Anti excitotoxic agents , Ion channel modulators, Metal Ion Chelators Free radical trappers, and others. 
The Cholinesterase inhibitors and NMDA receptor antagonists are used to treat Alzheimers. As the disease burden is high for this ailment, these drugs would command a major market share. However, the opportunity for emerging drugs is high, as CNS disorders involve an interplay of highly complex and multi- factorial processes & pathways.  Therefore, investment in research and development would have high pay offs.

Neuroprotective Products Market by use in the treatment of Medical Conditions
The neuroprotective drugs are used in the treatment of Alzheimer's disease, Multiple sclerosis, Parkinson's disease, Brain injury, Huntington's disease, Retinal disorders, Amyotrophic lateral sclerosis (ALS), Neuropathies, and other disorders affecting the nervous system.
According to the Alzheimer's association, an estimated 5.2 million Americans have Alzheimer's and it is the 6th leading cause of death accounting for the death of more than 500,000 persons per year in the United States. Hence, the market for treatment of Alzheimers is huge and it would spur the development of neuroprotective drugs.

Neuroprotective Market by Geography
The market is segmented by geography into North America, Europe, Asia Pacific and RoW. In the United States, death due to Alzheimers increased by 68 percent during 2000 to 2010. According to the Parkinson Disease foundation, 60,000 Americans are diagnosed of Parkinsons each year. Hence, North America is the major market for these products. World ‐wide, an estimated five to seven million people are living with Parkinson disease, which would increase the demand for neuroprotective drugs and spur research and development. Europe and Asia Pacific would also see an increased demand as the cases for neurodegenerative diseases increases in these regions.

Competitive Analysis
Genervon Biopharmaceuticals, NeuroVive Pharmaceutical,Ceregene, BHRPharma LLC, Neuren Pharmaceuticals, Allon therapeutics, Inc., Bionure Inc. are some of the key players in this market. In 2013, Bionure and The Myelin Repair Foundation (MRF) entered into a collaborative partnership agreement with the aim of advancing development of therapeutics for multiple sclerosis. This partnership would enable the commercialization of many promising compounds for the treatment of multiple sclerosis.

High Level Analysis
An overview of the neuroprotective market by segmentation of the market by type, application and geography, identifies the opportunities as well as associated risks in this market. Porter’s five force model analyzes the bargaining power of the supplier and buyer  as well as the threat posed by substitutes and new entrants which would enable a deeper understanding of changing market dynamics. The report helps to identify market leaders and the strategic business decisions taken by them. The impact of drivers, restraints and opportunities and other market dynamics are described in detail.

KEY BENEFITS

  • Competitive analysis of companies and policies adopted by competitors  would help in making strategic decisions
  • In-depth analysis of current market scenario would help in understanding opportunities in this market
  • Segmentation based on applications would help in understanding future growth prospects and areas where investments can be made.
  • Analysis of drivers and restrains focuses on the opportunities and risks of this market, which would enable decision-making
  • Estimations of growth in this market based on upcoming drugs would give an overall idea of areas of growth to stakeholders. 

KEY DELIVERABLES
The market is segmented by type of drugs, use in treatment of medical conditions and geography.

Neuroprotective Products Market by Class of Drugs

  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Anti-inflammatory and anti-apoptotic agents
  • Neurotropic factors
  • Mitochondrial dysfunction regulators
  • Metal Ion Chelators
  • Ion channel modulators
  • Ion channel modulators
  • Free radical trappers
  • Anti excitotoxic agents
  • Others

Neuroprotective Products Market by use in the treatment of Medical Conditions

  • Alzheimer's disease
  • Multiple sclerosis
  • Parkinson's disease
  • Ocular degeneration (retinal disorders)
  • Amyotrophic lateral sclerosis (ALS)
  • Huntington's disease
  • Neuropathies
  • Brain injury
  • Other disorders affecting the nervous system.

Neuroprotective Market by Geography

  • North America
  • Europe
  • Asia Pacific 
  • Rest of the World

 

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Medical Laboratories Asia-Pacific Market Research Report, 2013 - 2020

<p style="text-align:justify"><span style="color:rgb(0, 0, 0)"><span style="font-size:14px"><span style="font-family:arial,helvetica,sans-serif">Medical laboratories are independent, commercial enterprises that provide analytic services

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020

Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Opportunities and Forecasts, 2014 - 2020

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

Global Weight Loss and Obesity Market (Dietary supplements, equipments, services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Obesity is a medical term used when excessive accumulation of fat occurs in the body. It may have numerous adverse effects on health, which increases the chances of occurrence of ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market (Types, Drugs and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Acute Lymphocytic/Lymphoblastic leukemia is a kind of blood or bone marrow cancer. It occurs in lymphocytes which are white blood cells. It can then easily spread to the other parts ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Injectable Drug Delivery Market (Formulation, Device, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Injectable drug delivery system is infusion method, which administers drug into body by piercing the skin with the help of syringe attached to the needle. Most popular route it follows ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850

Read More >>

2017 © Copyright Big Market Research

View Pricing >>